Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) Operating Income: 2010-2024

Historic Operating Income for CorMedix (CRMD) over the last 15 years, with Dec 2024 value amounting to -$22.4 million.

  • CorMedix's Operating Income rose 1661.93% to $51.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $104.0 million, marking a year-over-year increase of 327.17%. This contributed to the annual value of -$22.4 million for FY2024, which is 54.34% up from last year.
  • CorMedix's Operating Income amounted to -$22.4 million in FY2024, which was up 54.34% from -$49.0 million recorded in FY2023.
  • CorMedix's Operating Income's 5-year high stood at -$22.4 million during FY2024, with a 5-year trough of -$49.0 million in FY2023.
  • For the 3-year period, CorMedix's Operating Income averaged around -$34.0 million, with its median value being -$30.6 million (2022).
  • In the last 5 years, CorMedix's Operating Income plummeted by 59.87% in 2023 and then surged by 54.34% in 2024.
  • Yearly analysis of 5 years shows CorMedix's Operating Income stood at -$27.2 million in 2020, then decreased by 8.14% to -$29.4 million in 2021, then fell by 4.03% to -$30.6 million in 2022, then slumped by 59.87% to -$49.0 million in 2023, then surged by 54.34% to -$22.4 million in 2024.